Trial Profile
To Assess Immune response to Bordetella pertussis vaccine in candidates and receptors of solid organ transplant
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Pertussis acellular vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- 24 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017